The results, as depicted in Figure 10A, demonstrated a significant increase in the expression levels of COL1A1, COL1A2, COL3A1, and FN1 in the GC sample group (n = 39) compared to the control group (n = 39, p-value < 0.05). This evidence concerns the gene FN1 and gastric cancer.